Printer Friendly

American Gene Technologies gets patent to protect experimental HIV treatment.

Byline: Daily Record Staff

A Maryland company that is working on a a cure for HIV has received a second patent to protect the unique molecule, methods, and cell processto make its product.

Rockville-based American Gene Technologies Inc. received the patent for its lentivirus vector AGT103, which it uses to manufacture its AGT103-T cell productintended to cure HIV, the company announced.

The new patent increases protection for composition of the therapeutic gene cargo in AGT103, the company said in a press release.

The company said it has been granted seven patents in the past 17 months, and expects to take its cure to clinical trials in 2019.

Copyright {c} 2019 BridgeTower Media. All Rights Reserved.

COPYRIGHT 2019 BridgeTower Media Holding Company, LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2019 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Daily Record (Baltimore, MD)
Date:May 23, 2019
Words:115
Previous Article:Court disbars veteran creditors' rights attorney for mishandling funds.
Next Article:Baltimore lubricants recycler buys European environmental services firm.
Topics:

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters